Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/2793Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Henderson , Rebecca M. | - |
| dc.date.accessioned | 2020-06-23T09:50:26Z | - |
| dc.date.available | 2020-06-23T09:50:26Z | - |
| dc.date.issued | 2007-04 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/2793 | - |
| dc.language.iso | en | en_US |
| dc.publisher | MIT Management Sloan School | en_US |
| dc.subject | Strategy | en_US |
| dc.title | Eli Lilly’s Project Resilience: Anticipating the Future of the Pharmaceutical Industry | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Business Case Studies | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Eli Lilly’s Project Resilience Anticipating the Future of the Pharmaceutical Industry .pdf | 189.2 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.